Streetbeat News

Analyst Ratings

CVNA

Evercore ISI Group analyst Michael Montani maintains an In-Line rating on Carvana (NYSE:CVNA) and raises the price target from $142 to $157.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 10:47 am

BBIO

HC Wainwright & Co. has reiterated its Buy rating for BridgeBio Pharma (NASDAQ:BBIO) and maintained a price target of $43, indicating confidence in the company's future performance.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 10:44 am

SFM

Evercore ISI Group has upgraded Sprouts Farmers Market (NASDAQ:SFM) from In-Line to Outperform, raising the price target from $96 to $120.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 10:44 am

GOOGL

Evercore ISI Group has maintained an 'Outperform' rating on Alphabet but lowered its price target from $225 to $200.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 10:42 am

STRO

HC Wainwright & Co. has reiterated its Buy rating for Sutro Biopharma (NASDAQ:STRO) and maintained a price target of $12, indicating confidence in the company's future performance.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 10:41 am

FROG

Needham analyst Mike Cikos has reiterated a Buy rating on JFrog (NASDAQ:FROG) and maintained a price target of $33.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 10:39 am

YELP

B of A Securities has initiated coverage on Yelp with an Underperform rating and set a price target of $30.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 10:39 am

COYA

HC Wainwright & Co. has initiated coverage on Coya Therapeutics with a Buy rating and set a price target of $18.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 10:38 am

CDTX

HC Wainwright & Co. analyst Ed Arce has reiterated a Buy rating for Cidara Therapeutics (NASDAQ:CDTX) and maintained a price target of $24.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 10:35 am

DKNG

Needham analyst Bernie McTernan has reiterated a Buy rating on DraftKings (NASDAQ:DKNG) and maintained a price target of $60.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 10:29 am